Fig. 1: Risks and burdens of post-acute sequelae of SARS-CoV-2 infection (PASC). | Nature Communications

Fig. 1: Risks and burdens of post-acute sequelae of SARS-CoV-2 infection (PASC).

From: Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status

Fig. 1: Risks and burdens of post-acute sequelae of SARS-CoV-2 infection (PASC).

Organ systems are presented in bolded font. Post-acute sequelae were ascertained from 30 days after infection until the end of follow-up. Hazard ratio and 95% confidence intervals are presented in the left panel and burdens per 1000 COVID-19 patients at 6 months are presented in the right panel; right limit of the bar represents estimated burden and error bars represent the 95% confidence interval. Models were adjusted for age, race, sex, receipt of long-term care, Area Deprivation Index, number of outpatient encounters, number of hospital admissions, number of outpatient prescriptions, number of outpatient serum creatinine measurements, chronic lung disease, cancer, cardiovascular disease, cerebrovascular disease, dementia, diabetes mellitus, hypertension, hyperlipidemia, depression, anxiety, chronic kidney disease, hepatitis C and peripheral artery disease, overweight, obesity, smoking status, Charlson Comorbidity Index, US geographic region, total number of beds, number of COVID-19 tests administered, COVID-19 positivity rate, and average hospital bed occupancy during the week of participant enrollment.

Back to article page